2021
Towards harmonised criteria in quality assurance and quality control of suspect and non-target LC-HRMS analytical workflows for screening of emerging contaminants in human biomonitoring
CABALLERO-CASERO, Noelia, Lidia BELOVA, Philippe VERVLIET, Jean-Philippe ANTIGNAC, Argelia CASTANO et. al.Základní údaje
Originální název
Towards harmonised criteria in quality assurance and quality control of suspect and non-target LC-HRMS analytical workflows for screening of emerging contaminants in human biomonitoring
Autoři
CABALLERO-CASERO, Noelia (56 Belgie), Lidia BELOVA (56 Belgie), Philippe VERVLIET (56 Belgie), Jean-Philippe ANTIGNAC (250 Francie), Argelia CASTANO (724 Španělsko), Laurent DEBRAUWER (250 Francie), Marta Esteban LOPEZ (724 Španělsko), Carolin HUBER (276 Německo), Jana KLÁNOVÁ (203 Česká republika, garant, domácí), Martin KRAUSS (276 Německo), Arjen LOMMEN (528 Nizozemské království), Hans G. J. MOL (528 Nizozemské království), Herbert OBERACHER (40 Rakousko), Olga PARDO (724 Španělsko), Elliott James PRICE (826 Velká Británie a Severní Irsko, domácí), Vera REINSTADLER (40 Rakousko), Chiara Maria VITALE (380 Itálie, domácí), Alexander L. N VAN NUIJS (56 Belgie) a Adrian COVACI (56 Belgie)
Vydání
TrAC Trends in Analytical Chemistry, Oxford, Elsevier, 2021, 0165-9936
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10406 Analytical chemistry
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 14.908
Kód RIV
RIV/00216224:14310/21:00122041
Organizační jednotka
Přírodovědecká fakulta
UT WoS
000637644000003
Klíčová slova anglicky
Quality control-quality assurance measures; Framework for analytical performance; Emerging compounds; Human matrices; Suspect and non-target screening; HBM4EU
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 4. 8. 2021 22:29, Mgr. Michaela Hylsová, Ph.D.
Anotace
V originále
Although the exposure assessment of chemicals of emerging concern (CECs) has taken a decisive step forward through advances in (bio)informatics, statistics, and the development of highly sophisticated analytical instruments, the lack of standardisation and harmonisation of analytical workflows and method performance assessment for suspect and non-target screening hampers the interpretation of results, their comparability and thus, its transmission to policymakers. To date, unlike in other research fields such as forensics or food analysis, there is a lack of guidelines for non-target analysis in human risk assessment and quality assurance and quality control (QA/QC) protocols. Moreover, the majority of efforts have been focused on the development and implementation of QA/QC actions for data acquisition, data analysis and mining, largely neglecting the sample preparation necessary for determination of CECs by suspect and non-target screening methods. In this article, we propose a set of QA/QC measures that covers sampling, sample preparation and data acquisition, as an aspect of work conducted within the European Biomonitoring for Europe initiative (HBM4EU). These measures include the use of standardised terminology and the implementation of dedicated QA/QC actions in each stage of the analytical process. Moreover, a framework for the analytical performance assessment has been developed for the first time for the identification of CECs in human samples by suspect and non-target approaches. Adoption of the actions proposed here for the identifi-cation of CECs in human matrices can significantly improve the comparability of reported results and contribute to the (challenging) Exposome research field.
Návaznosti
EF16_027/0008360, projekt VaV |
| ||
733032, interní kód MU |
|